Dr. David Levy
DirectorDr. David Levy is the Chief Executive Officer at EHE. He is an accomplished physician executive with a record of achievement in founding, leading, and/or turning around a variety of health services companies focused on improving human health.
As a primary care physician and epidemiologist, Dr. Levy started his career in private practice in suburban New York City. There he founded Franklin Health Inc., (now owned by Optum), the innovator and leader in advocating for patients with highly complex illnesses. He then went on to PwC, and as a partner ultimately led its global health care business for several years. Dr. Levy serves on the boards of leading device, technology, and services companies in the US, Israel, and Brazil.
Dr. Levy is a renowned strategic thinker who has executed effective strategies for his own enterprises and a diverse set of public and private sector entities. Drawing on a vast network of business relationships, Dr. Levy brings global best-in-practice solutions to the healthcare industry.
Chairman of the boardJoe is Chairman of AposHealth and an investor in healthcare. Over the last 16 years he led investments and held director/ ceo/coo positions in the payor, provider and drug distribution sectors. In the aggregate over $2 billion of incremental exit value was realized on these investments. Previously he was a venture capitalist and an investment banker. He is a graduate of Columbia University and the Wharton Graduate School of Business.
Dr. Michael Stocker, MD, MPH
DirectorDr. Stocker served as Chairman of the Board, for the New York City Health and Hospitals Corporation (HHC) from 2008 to 2014. He was appointed by former Mayor Michael Bloomberg. HHC is the largest municipal hospital and healthcare system in the country, serving 1.3 million New Yorkers annually.
Dr. Stocker has an impressive, wide-ranging career spanning the field of healthcare. Most recently, he served as Corporate Executive Vice President of WellPoint Inc. Before WellPoint absorbed Empire Blue Cross and Blue Shield, he was Empire’s Chief Executive Officer. Prior to joining Empire, Dr. Stocker held the positions of President of Cigna Health Plans and General Manager of the New York Area of US Healthcare. Before moving to New York, Dr. Stocker was a practicing physician in Chicago, serving as Associate Chairman of the Department of Family Practice at Cook County Hospital in Chicago (the area’s public hospital) from 1975 to 1980. He also served as Medical Director of Anchor Organization for Health Maintenance at Rush Presbyterian St. Luke’s Medical Center in Chicago from 1980 to 1985.
Dr. Stocker’s voluntary activities complement his professional career. He is a board member of the Arthur Ashe Institute for Urban Health and is currently serving on the Board of Montefiore Medical Center. His expertise in healthcare administration has made him a valued member of oversight and good government organizations such as the Citizens Budget Commission of New York and The Partnership for New York City, Inc. He served as a member of the New Jersey Governor’s Health Care Cost Reduction Advisory Committee and the National Committee for Quality Assurance.
Dr. Stocker was educated at the University of Notre Dame and received his MD from the Medical College of Wisconsin in 1968. He received his post-graduate training at the Mayo Clinic and the University of California and is board-certified in Internal Medicine and Family Practice. Dr. Stocker also holds a Master’s degree in Public Health received from the University of Michigan in 1987.
Uri Yaron, Ph.D.
DirectorUri is a HealthTech and Life Sciences investment Executive who serves on multiple Boards. In his previous role he served as the WW President of Biosense Webster (BWI), a member of the Johnson & Johnson Family of Companies. Uri joined BWI in 1996, a year prior to its acquisition by J&J. Prior to his WW President role, Uri has held several positions of increasing responsibilities in R&D, Business Development and General Management at Biosense Webster, Cordis, Cerenovus, Mentor, Acclarent, ASP & Sterilmed.
Uri is known as a strategic leader who established outstanding relationships with both customers and external partners, creating significant value for J&J in the Cardiovascular space. He has a proven track record of driving innovation and growth and adapting the company’s business model to a rapidly changing and increasingly challenging external environment. Under Uri’s Leadership, BWI teams have won 5 Johnson Medals, the most prestigious award given for research & development excellence within J&J.
Uri holds a PhD in Physics from the Hebrew University of Jerusalem, summa cum laude. Prior to joining BWI, Uri was a Member of the Technical Staff at the Micro-Physics Research Lab of AT&T Bell Laboratories. He is a co-author of over 40 peer-reviewed papers, including papers in Nature and Physical Review Letters, and the co-inventor of over 10 US patents.
Uri serves on the Board of Directors of the Western States of the American Heart Association. He was the Chairperson of the 2020 LA Heart & Stroke Walk. In addition, Uri teaches an MBA course at the BioMed MBA Program of the Hebrew University, and coaches senior combat officers of the Israeli Defense Forces.